{
    "N/R/U": null,
    "Applicant": "Hospira Inc., a Pfizer Company",
    "BLA Number": "125545",
    "Proprietary Name": "Retacrit",
    "Proper Name": "epoetin alfa-epbx",
    "BLA Type": "351(k) Biosimilar",
    "Strength": "20,000UNITS/ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous, Subcutaneous ",
    "Product Presentation": "Multi-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "June 30, 2020",
    "Ref. Product Proper Name": "epoetin alfa",
    "Ref. Product Proprietary Name": "Procrit",
    "Supplement Number": "5",
    "Submission Type": "Supplement",
    "License Number": "1974",
    "Product Number": "007",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}